The Syringe Isn't a Neutral Detail. My Op-Ed on Delivery-Device Provenance

On September 3, Australia's Therapeutic Goods Administration quietly updated its review of plastic syringes used in medical procedures. It received almost no attention next to the injectable-safety headlines running the same week. I think that is backwards. A patient can verify the brand name printed on a filler box and still be exposed to risk through the syringe delivering it, and almost no consumer-facing safety conversation ever mentions the syringe at all.

Why the delivery device is not a neutral detail

Prefilled syringes are engineered as part of the product: barrel material, plunger seal, needle gauge, and dead-space volume are all specified and tested together with the formulation inside them. A mismatched or substituted syringe can change dosing accuracy, introduce contamination risk, or fail mechanically during injection. When a practice repackages or transfers product into a different syringe than the one it was validated in, they have altered the product whether or not they think of it that way. I do not think most patients realize this happens, and I do not think most practices volunteer it.

Where I think this connects to the counterfeit problem

Counterfeit and diverted injectable product is frequently sold without its original, validated delivery system, because the packaging is one of the easier things to strip away or substitute. A practice buying gray-market product often has to solve the syringe problem separately from the product problem, and that second, quieter substitution is exactly the kind of detail a patient has no way to see or ask about during a consultation. Product-name verification catches the more visible half of the counterfeit problem. It does very little to catch this half.

What I'd want practices to disclose

I think a reasonable standard is simple: product should reach the patient in its original, manufacturer-validated delivery system, unopened until the moment of use, and a practice should be able to say so plainly if asked. That is the standard I hold my own practice in Alpharetta to, and I think it deserves to be a normal question at any consultation in North Fulton or anywhere else — not because most practices are doing this wrong, but because almost no one currently asks, and an unasked question is an easy one to quietly fail.

— Dr. Iryna Lazuk, MD, Lazuk Esthetics, Alpharetta, Georgia